Secondary
Revance Therapeutics, Inc.
Revance is a clinical-stage biotechnology company focused on the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic indications.
Symbol
RVNC
Last Closing Price
$33.65
Effective Date
December 7, 2017
Underwriters
Goldman Sachs, Cowen
To view the prospectus for Revance Therapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277